Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and/or lymphopenia (RELEASE NCT04578210).

Saved in:
Bibliographic Details
Title: Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and/or lymphopenia (RELEASE NCT04578210).
Authors: Ferreras C; Hospital La Paz Institute for Health Research, IdiPAZ, University Hospital La Paz, Madrid, Spain., Hernández-Blanco C; Internal Medicine Department, Hospital de Emergencias Enfermera Isabel Zendal, Madrid, Spain., Martín-Quirós A; Emergency Unit, Internal Medicine Department, University Hospital La Paz, Madrid, Spain., Al-Akioui-Sanz K; Hospital La Paz Institute for Health Research, IdiPAZ, University Hospital La Paz, Madrid, Spain., Mora-Rillo M; Infectious Diseases Unit, Internal Medicine Department, University Hospital La Paz, Hospital La Paz Institute for Health Research, IdiPAZ, Consorcio Centro de Investigación Biomédica en Red CIBER-Infec, Madrid, Spain., Ibáñez F; Internal Medicine Department, Hospital Puerta de Hierro, Madrid, Spain., Díaz-Almirón M; Biostatistics Department, La Paz University Hospital, Madrid, Spain., Cano-Ochando J; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Centro Nacional de Microbiologia, Instituto de Salud Carlos III, 28220 Madrid, Spain; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Lozano-Ojalvo D; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Jiménez-González M; Infectious Diseases Unit, Internal Medicine Department, University Hospital La Paz, Hospital La Paz Institute for Health Research, IdiPAZ, Consorcio Centro de Investigación Biomédica en Red CIBER-Infec, Madrid, Spain; Clinical Trials Unit (UCICEC) at Hospital La Paz Institute for Health Research, IdiPAZ, University Hospital La Paz, Madrid, Spain., Goterris R; Hematology Department, Hospital Clinico Universitario, Valencia, Spain., Sánchez-Zapardiel E; Immunology Department, University Hospital La Paz, Madrid, Spain., de Paz R; Hematology Department, University Hospital La Paz, Madrid, Spain., Guerra-García P; Hospital La Paz Institute for Health Research, IdiPAZ, University Hospital La Paz, Madrid, Spain; Pediatric Hemato-Oncology Department, University Hospital La Paz, Madrid, Spain., Queiruga-Parada J; Clinical Pharmacology Department, University Hospital La Paz, Madrid, Spain., Molina P; Clinical Pharmacology Department, University Hospital La Paz, Madrid, Spain., Briones ML; Neumology Department, Hospital Clinico Universitario, Valencia, Spain., Ruz-Caracuel B; Hospital La Paz Institute for Health Research, IdiPAZ, University Hospital La Paz, Madrid, Spain., Borobia AM; Hospital La Paz Institute for Health Research, IdiPAZ, University Hospital La Paz, Madrid, Spain; Clinical Trials Unit (UCICEC) at Hospital La Paz Institute for Health Research, IdiPAZ, University Hospital La Paz, Madrid, Spain; Clinical Pharmacology Department, University Hospital La Paz, Madrid, Spain., Carcas AJ; Clinical Trials Unit (UCICEC) at Hospital La Paz Institute for Health Research, IdiPAZ, University Hospital La Paz, Madrid, Spain; Clinical Pharmacology Department, University Hospital La Paz, Madrid, Spain; Faculty of Medicine Universidad Autónoma de Madrid, Madrid, Spain., Planelles D; Department of Histocompatibility, Centro de Transfusión de la Comunidad Valenciana, Valencia, Spain., Vicario JL; Histocompatibility, Centro de Transfusión de la Comunidad de Madrid, Madrid, Spain., Moreno MÁ; Histocompatibility, Centro de Transfusión de la Comunidad de Madrid, Madrid, Spain., Balas A; Histocompatibility, Centro de Transfusión de la Comunidad de Madrid, Madrid, Spain., Llano M; Infectious Diseases Department, Hospital de Emergencias Enfermera Isabel Zendal, Madrid, Spain., Llorente A; Infectious Diseases Department, Hospital de Emergencias Enfermera Isabel Zendal, Madrid, Spain., Del Balzo Á; Emergency Unit, Internal Medicine Department, University Hospital La Paz, Madrid, Spain., Cañada C; Emergency Unit, Internal Medicine Department, University Hospital La Paz, Madrid, Spain., García MÁ; Emergency Unit, Internal Medicine Department, University Hospital La Paz, Madrid, Spain., Calvin ME; Emergency Unit, Internal Medicine Department, University Hospital La Paz, Madrid, Spain., Arenas I; Emergency Unit, Internal Medicine Department, University Hospital La Paz, Madrid, Spain., Pérez de Diego R; Laboratory of Immunogenetics of Human Diseases, IdiPAZ Institute for Health Research, La Paz University Hospital, Madrid, Spain; Innate Immunity Group, IdiPAZ Institute for Health Research, La Paz University Hospital, Madrid, Spain; Interdepartmental Group of Immunodeficiencies, Madrid, Spain., Eguizábal C; Research Unit, Basque Centre for Blood Transfusion and Human Tissues, Osakidetza, Bizkaia, Spain; Biocruces Bizkaia Health Research Institute, Bizkaia, Spain., Soria B; Health Research Institute-ISABIAL, Alicante University Hospital and Institute of Bioengineering, Miguel Hernández University, Alicante, Spain; University Pablo de Olavide, Sevilla, Spain., Solano C; Hematology Department, Hospital Clinico Universitario, Valencia, Spain; Department of Medicine, University of Valencia, Valencia, Spain., Pérez-Martínez A; Hospital La Paz Institute for Health Research, IdiPAZ, University Hospital La Paz, Madrid, Spain; Pediatric Hemato-Oncology Department, University Hospital La Paz, Madrid, Spain; Faculty of Medicine Universidad Autónoma de Madrid, Madrid, Spain. Electronic address: aperezmartinez@salud.madrid.org.
Source: Cytotherapy [Cytotherapy] 2024 Jan; Vol. 26 (1), pp. 25-35. Date of Electronic Publication: 2023 Oct 29.
Publication Type: Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-2566 (Electronic) Linking ISSN: 14653249 NLM ISO Abbreviation: Cytotherapy Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1477-2566
DOI:10.1016/j.jcyt.2023.10.002